MTTlab and Giotto Biotech have entered into a collaboration to expand their respective services portfolio in the field of preclinical drug development. Thanks to this new cooperation, Giotto Biotech and MTTlab will be able to widen their expertise and launch new services and product offers.
A co-development project proposed by MTTlab, CEMSLab from the University of Trieste and Fluigent SA has been awarded funding from the Made In Trieste research program. The goal of the project is development of a millifluidic device as alternative method to animal testing.
MTTlab Srl will be present at the B2B brokerage @ EURO BIO HIGH TECH, in Trieste, Stazione Marittima, on September 21st – 22nd, 2017. The matchmaking event is organised in the framework of the Euro Bio High Tech, the first showcase devoted to innovation in the biomedical sector, biotechnology and bioinformatics in Central & Eastern Europe and Western Balkans. …
Read more
We are pleased to present an example of the tissue-specific molecular pharmacology protocol for drug development. In collaboration with our partners we can enhance the readout of in vivo / ex vivo pharmacology study by evaluating the drug candidate mode of action at a cellular level, by providing molecular pharmacology data in various tissue compartments and…
Read more
Trieste, Italy and Groningen, The Netherlands (September 2017) MTTlab Srl and Vivomicx BV today announce their collaboration to make the trajectory of preclinical drug discovery & development more efficient by providing more in-depth information from the preclinical tissue samples. The collaboration covers joint marketing and joint execution of preclinical testing combining the expertise of both…
Read more